SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense scrutiny and volatility following an earnings report that featured a double-beat but was overshadowed by weak sales outlooks and ongoing struggles in the Chinese market. The community is deeply polarized, with many investors debating whether the stock's multi-year lows represent a generational buying opportunity or evidence of a brand in long-term decline amidst stiff competition and political headwinds.

Tema ETF Trust - Tema Space Innovators ETF

Investors are actively debating the potential of the newly launched space-focused ETF, with many drawing comparisons to other high-volatility funds due to its significant exposure to companies like SpaceX. Sentiment is mixed as participants weigh the excitement over the sector's growth potential against questions regarding the fund's underlying structure and liquidity.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending as market participants debate the stock's massive exposure to Bitcoin and the implications of its ongoing capital-raising strategy, which involves significant share dilution. Community discussions are highly polarized, pitting bulls who view recent price dips as a prime accumulation opportunity against bears who express deep skepticism regarding the firm's debt load and long-term sustainability.

Ganymede

Investors are actively accumulating Ganymede, focusing on its stable structure and disciplined price action while debating the potential for a community-driven surge.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor the company's transition into a commercial-stage biotech following the recent FDA approval of Yartemlea and a high-value partnership with Novo Nordisk. The community remains focused on the early commercial launch trajectory, upcoming milestone payments, and the stock's significant potential for rerating as institutional interest grows.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently trending as investors view the stock as a key proxy for gaining pre-IPO exposure to SpaceX, driven by the company's significant equity stake and ongoing spectrum monetization deals. Community discussion is focused on the potential for a massive valuation increase, with many closely tracking rumors of a secondary stock sale and the structural impacts of upcoming index inclusion.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened community discussion as investors look toward the company's transition from R&D to production, with participants closely monitoring forward guidance for upcoming unit shipments and revenue. While some stakeholders express frustration over the timing of production milestones and lack of recent order disclosures, others are actively connecting POET's photonics technology to broader AI ecosystem shifts involving major hardware suppliers and hyperscalers.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending as investors react to the upcoming earnings release and intense speculation surrounding a potential acquisition, with the community actively debating whether a deal with a major industry player is imminent. While bulls are focused on the strategic value of the company's spectrum assets and recent partnership news, discussion remains heavily split between those anticipating a high-premium buyout and skeptics concerned about long-term valuation and past performance.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending after receiving FDA approval for Empaveli to treat rare kidney diseases, a catalyst that has bolstered sentiment regarding its expanded immunology portfolio. Investors are closely monitoring the company's commercial execution and ability to drive revenue growth as they balance these clinical milestones against ongoing discussions surrounding management's efficiency.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors focus on the upcoming Phase 3 VELA trial data presentation at the AAD annual meeting, which is expected to reinforce the stock's best-in-class potential for treating hidradenitis suppurativa. Community sentiment remains highly bullish, with active discussions centering on the potential for an imminent buyout and the belief that the stock is significantly undervalued by analysts relative to its long-term scientific merit.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cannabis Suisse Corp. engages in the rental of commercial office and industrial space. The company was founded on February 26, 2016 and is headquartered in Jacksonville, FL.

Cannabis Suisse Corp

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

Current Price	$0.0061
Prev Close	$0.0061
Open	$0.0061
Dividend Yield	0.00%
50-Day Moving Average	$0.0096
Beta	0.78
Avg. Volume	6,629.53
PE Ratio	6.10

52-Week High	$0.0245
52-Week Low	$0.0028
Market Capitalization	$431,154.00
EPS (Annual)	-$0.0064
Price to Book	-0.24
Revenue Per Employee	N/A

CSUI
Cannabis Suisse Corp

Feed

News

Sentiment

Fundamentals

Info

Latest CSUI News

CSUICannabis Suisse Corp